151 Followers on Owler

Evolve Biosystems

Read more
Timothy B. Brown's photo - CEO of Evolve Biosystems

CEO

Timothy B. Brown

CEO Approval Rating

83/100

Founded:

2011

Status:

PrivateIndependent Company

Est. Annual Revenue
$5.3M
Agree?
Est. Employees
49
Agree?

EVOLVE BIOSYSTEMS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Evolve Biosystems's company profile
Timothy B. Brown's photo - CEO of Evolve Biosystems

Timothy B. Brown

CEO

83/100
49
$135.3M
$5.3M
View Profile
1
Evolve Biosystems's Competitor - Seres Therapeutics logo
Eric D. Shaff's photo - President & CEO of Seres Therapeutics

Eric D. Shaff

President & CEO

89/100
145
$267.9M
$30M
View Profile
2
Evolve Biosystems's Competitor - Finch Therapeutics logo
Mark Smith's photo - CEO of Finch Therapeutics

Mark Smith

CEO

86/100
131
$312.9M
$10.3M
View Profile
3
Evolve Biosystems's Competitor - Vedanta logo
Bernat Olle's photo - Co-Founder & CEO of Vedanta

Bernat Olle

Co-Founder & CEO

84/100
90
$308.6M
$8M
View Profile
4
Evolve Biosystems's Competitor - Second Genome logo
Karim Dabbagh's photo - President & CEO of Second Genome

Karim Dabbagh

President & CEO

86/100
60
$68.7M
$12M
View Profile
5
Evolve Biosystems's Competitor - MicroBiome Therapeutics, LLC logo
Dale R. Pfost's photo - Co-Founder & CEO of MicroBiome Therapeutics, LLC

Dale R. Pfost

Co-Founder & CEO

89/100
46
$4.1M
$10.6M
View Profile
6
Evolve Biosystems's Competitor - uBiome logo
CEO Avatar

CEO

- -
96
$120.6M
$32M
View Profile
7
Evolve Biosystems's Competitor - Thryve logo
Richard Lin's photo - Co-Founder & CEO of Thryve

Richard Lin

Co-Founder & CEO

92/100
20
$1.9M
$2M
View Profile
8
Evolve Biosystems's Competitor - DayTwo logo
David Henderson's photo - CEO of DayTwo

David Henderson

CEO

82/100
100
$85M
$8M
View Profile
9
Evolve Biosystems's Competitor - Viome logo
Naveen Jain's photo - Founder & CEO of Viome

Naveen Jain

Founder & CEO

82/100
110
$91.1M
$20M
View Profile
10
Evolve Biosystems's Competitor - Shoreline Biome logo
Bill McKenzie's photo - CEO of Shoreline Biome

Bill McKenzie

CEO

90/100
25
$3.5M
$2M
View Profile
11
Evolve Biosystems's Competitor - Biome Makers logo
Adrian Ferrero Fernandez's photo - Co-Founder & CEO of Biome Makers

Adrian Ferrero Fernandez

Co-Founder & CEO

90/100
20
$21.2M
$3M
View Profile
12
Evolve Biosystems's Competitor - ViThera Pharmaceuticals logo
Bernard Malfroy Camine's photo - President & CEO of ViThera Pharmaceuticals

Bernard Malfroy Camine

President & CEO

70/100
10
- -
$2M
View Profile

Missing a competitor? Contribute!

Seres Therapeutics is seen as one of Evolve Biosystems's biggest rivals. Seres Therapeutics was founded in 2010 in Cambridge, Massachusetts. Like Evolve Biosystems, Seres Therapeutics also operates in the Biotechnology sector. Seres Therapeutics generates $24.7M more revenue than Evolve Biosystems.

Finch Therapeutics is one of Evolve Biosystems's top competitors. Finch Therapeutics was founded in 2017, and its headquarters is in Somerville, Massachusetts. Like Evolve Biosystems, Finch Therapeutics also operates in the Biotechnology space. Finch Therapeutics has 82 more employees than Evolve Biosystems.

Vedanta is one of Evolve Biosystems's top rivals. Vedanta was founded in 2010, and is headquartered in Cambridge, Massachusetts. Like Evolve Biosystems, Vedanta also works within the Biotechnology sector. Vedanta generates $2.7M more revenue vs. Evolve Biosystems.

Evolve Biosystems Acquisitions

No recent acquisitions found related to Evolve Biosystems

Evolve Biosystems Funding History

Since Evolve Biosystems was founded in 2011, it has participated in 6 rounds of funding. In total Evolve Biosystems has raised $135.3M. Evolve Biosystems' last funding round was on Feb 2021 for a total of $65.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series D
Feb 2021
$65M
Debt - PPP (CARES Act)
Jun 2020
$350K - $1M
Series C
Jun 2018
$40M
Series B
May 2017
$20M
Series A
Jul 2015
$9M

Since Evolve Biosystems was founded in 2011, it has participated in 6 rounds of funding. In total Evolve Biosystems has raised $135.3M. Evolve Biosystems' last funding round was on Feb 2021 for a total of $65.0M

Evolve Biosystems Investments

No recent investments found related to Evolve Biosystems

Evolve Biosystems News

February 10, 2021FoodNavigator-USA

Evolve BioSystems gets $55 million investment led by Cargill

Evolve BioSystems has announced $55 million in funding from Cargill and a private equity firm to brin... See more »
February 10, 2021Nutrition Insight

Cargill leads US$55M funding round for Evolve BioSystems' probiotic targeting infant gut dysbiosis

10 Feb 2021 --- US-based Evolve BioSystems has landed US$55 million for the commercialization of its ... See more »
March 26, 2020firstwordpharma

Evolve BioSystems, Inc. Announces Collaboration with Janssen to Study the Impact of B. infantis EVC001 in the Reduction of Atopic Dermatitis

Evolve BioSystems, Inc., a global leader dedicated to improving human health through the gut microbio... See more »
March 25, 2020Reuters

CORRECTED-BRIEF-Evolve Biosystems Announces Collaboration With Janssen

* EVOLVE BIOSYSTEMS INC. ANNOUNCES COLLABORATION WITH JANSSEN TO STUDY IMPACT OF B. INFANTIS EVC001 I... See more »
February 25, 2020NutraIngredients

Bill Gates-backed probiotic firm to embark on research in Singapore, Hong Kong

Evolve BioSystems, the US-based microbiome firm supported by big name investors Bill Gates and Li Ka ... See more »
December 9, 2019FoodNavigator-USA

RB partners with Evolve BioSystems on infant probiotic products

The new partnership leverages RBâs national reach to expanding the reach and adoption of Evivo, Evolv... See more »
December 5, 2019BioSpace

RB and Evolve BioSystems Team Up to Advance Infant Gut Health

RB and Evolve BioSystems announce a partnership in the sale of Evivo®, Evolve BioSystems' infant prob... See more »

Evolve Biosystems Press Releases

August 14, 2019PR Newswire

Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants

DAVIS, Calif., Aug. 14, 2019 /PRNewswire/ -- Evolve BioSystems, Inc. today announced findings from a ... See more »
June 4, 2019PR Newswire

Top Medical Professionals Gather to Tackle Infant Gut Dysbiosis

DAVIS, Calif., June 4, 2019 /PRNewswire/ -- Evolve BioSystems, makers of Evivo® baby probiotic, today... See more »
September 20, 2018PR Newswire

First-Ever Rapid Response Test for Levels of Bifidobacterium in Baby's Gut Microbiome

DAVIS, Calif., Sept. 20, 2018 /PRNewswire/ -- Evolve BioSystems, makers of Evivo® baby probiotic, tod... See more »
July 18, 2018StreetInsider

Significant Reduction in Pathogenic Gut Bacteria Lowers Potential for Infection Risk in Infants Fed B. infantis EVC001

Evolve BioSystems, Inc. (www.evolvebiosystems.com) announced publication of a study showing that two ... See more »
April 17, 2018PR Newswire

Landmark Study To Address Global Malnutrition And Restorative Effect Of Infant Probiotic

DAVIS, Calif., April 17, 2018 /PRNewswire/ -- Evolve BioSystems, Inc. and the icddr,b (International ... See more »
December 11, 2017StreetInsider

Evivo with MCT Oil Now Available as Single Use Vial for Hospital Use

BioSystems, Inc. today announced a first-to-market, single-use liquid form of Evivo™ (activated B. in... See more »
December 20, 2016Blackbird

Evolve BioSystems Successfully Defends European Patent Opposition by Danone, Maintaining Their Position as Leaders in the Infant Gut Microbiome Space

DAVIS, CA - (Marketwired) - 12/20/16 - Evolve BioSystems, Inc., a microbiome company developing novel... See more »

Social Media

Evolve Biosystems Headquarters

2121 2nd Street Suite B107

Davis, California95618

530-747-2012

Driving Directions »

Trending Companies

Evolve Biosystems Summary

ABOUT

Overview

Evolve Biosystems is a California-based biotechnology company that develops and commercializes probiotic-based biotherapeutics for infants. Evolve Biosystems was founded in 2011. Evolve Biosystems' headquarters is located in Davis, California, USA 956...

CEO

Evolve Biosystems's CEO, Timothy B. Brown, currently has an approval rating of 83%. Evolve Biosystems's primary competitors are Seres Therapeutics, Finch Therapeutics & Vedanta.

Frequently Asked Questions about Evolve Biosystems

  1. When was Evolve Biosystems founded?

    Evolve Biosystems was founded in 2011
  2. Who is Evolve Biosystems's CEO?

    Evolve Biosystems's CEO is Timothy B. Brown
  3. How much revenue does Evolve Biosystems generate?

    Evolve Biosystems generates $5.3M in revenue
  4. How much funding does Evolve Biosystems have?

    Evolve Biosystems has historically raised $135.3M in funding
  1. Where is Evolve Biosystems's headquarters?

    Evolve Biosystems's headquarters is in Davis California, USA
  2. How many employees does Evolve Biosystems have?

    Evolve Biosystems has 49 employees
  3. What sector does Evolve Biosystems operate in?

    Evolve Biosystems is in Life Sciences, Biotechnology
  4. Who are Evolve Biosystems's competitors?

    Evolve Biosystems's top competitors are Seres Therapeutics, Finch Therapeutics, Vedanta